Rūta Veinalde - Concepedia

Author

Rūta Veinalde

Heidelberg University ORCID

Also Known As

R. Veinalde, Rūta Veinalde, Veinalde, Rūta

Publications

700

Citations

H-Index

Concepts

All Affiliations

Heidelberg University Latvian Biomedical Research and Study Centre German Cancer Research Center University Hospital Heidelberg National Center for Tumor Diseases

About

Rūta Veinalde is an author at Heidelberg University specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	71
2	Immunology	3	3	71
3	Cell Biology	2	2	54
4	Cellular Physiology	1	1	11
5	Clinical Immunology	1	1	11

Rūta Veinalde

Publications

678

Citations

H-Index

Page 1

	Year	Citations
CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy Christine E. Engeland, Christian Grossardt, Rūta Veinalde, Molecular Therapy	2014	281
Melanoma prone families with <i>CDK4</i> germline mutation: phenotypic profile and associations with <i>MC1R</i> variants Hanne Puntervoll, Xiaohong R. Yang, Hildegunn Høberg‐Vetti, Journal of Medical Genetics	2013	135
Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors Tobias Speck, Johannes P.W. Heidbuechel, Rūta Veinalde, Clinical Cancer Research	2018	98
Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation Rūta Veinalde, Christian Grossardt, Laura Hartmann, OncoImmunology	2017	76
Immunological Effects and Viral Gene Expression Determine the Efficacy of Oncolytic Measles Vaccines Encoding IL-12 or IL-15 Agonists Rūta Veinalde, Laura Hartmann, Jessica Dunder, Viruses ImmunologyImmunoeditingImmunologic MechanismImmunotherapeuticsCd4 T Cell Responses	2019	43
Analysis of Latvian familial melanoma patients shows novel variants in the noncoding regions of CDKN2A and that the CDK4 mutation R24H is a founder mutation Rūta Veinalde, Aija Ozola, Kristīne Azarjana, Melanoma Research	2013	17
Oncolytic measles vaccines encoding PD-1 and PD-L1 checkpoint blocking antibodies to increase tumor-specific T cell memory Rūta Veinalde, Gemma Pidelaserra-Martí, Coline Moulin, Molecular Therapy — Oncolytics VaccinationPd-l1 CheckpointOncolytic Measles VaccinesTumor ImmunologyCancer Immunosurveillance	2021	17
<i>Ex vivo</i> cytokine production in peripheral blood mononuclear cells after their stimulation with ds<scp>RNA</scp> of natural origin Rūta Veinalde, Ramona Petrovska, Rüta Brüvere, Biotechnology and Applied Biochemistry Clinical ImmunologyNatural OriginImmune RegulationImmunologyBlood Cell	2013	11

Page 1